biotech / news / / Newsmax
AbbVie and Genentech will become the 10th and 11th participants in the TrumpRx program.
AbbVie and Genentech are the 10th and 11th companies to join the TrumpRx program.
KEY POINTS
- AbbVie will offer Humira at an 86% discount, reducing its price from $6,900 to about $950.
- Genentech will cut the price of Xofluza from $168 to about $50 for uninsured patients.
- The Trump administration is working to allow government insurance copays for TrumpRx drugs, pending congressional action.
- TrumpRx now offers over 61 discounted medications, up from about 40 at its February launch.
COMPANIES
Summarized by Newsio from Newsmax. How we summarize →